DISCO Pharmaceuticals GmbH

Learn more about DISCO here👉 bit.ly/4ifQmFM

👀 Check out @BioCentury's latest Emerging Company Profile series featuring our Roman Thomas who spoke @DanielleGolovin about our disruptive #surfaceome mapping technology. Read the profile using the link in the comments below 👇 #Proteomics #Optoproteomics #DrugDiscovery

Amazing night at the @lifestarawards where @DISCOPharma was presented with the Seed🌱Raise of the Year award 👏. Thank you to the 🥳 DISCO team and our investors for their support & dedication❤️! Congrats to all the winners and finalists! #lifestarawards

🔗 Learn more about DISCO's disruptive surfaceome mapping technology here: 👉discopharma.de

Catch @DISCO Pharma at Cancer R&D 2024 from 18-20 Nov! Connect🤝with Norbert Volkmar, Scientist at DISCO to learn more about how we accomplished the first-ever mapping of the #SCLC #surfaceome. #CancerResearch

@OptimumComms 📣Listen to our CEO Roman Thomas in the #LungCancerAwarenessMonth episode of the #OptimumPerspectives Podcast as he discusses the breakthroughs in #lungcancer treatments and @DISCOPharma to develop its #surfaceome mapping platform. @health_journo @OptimumComms

🎙️In this podcast to mark #LungCancerAwarenessMonth, Optimum’s Richard Staines speaks to Roman Thomas, CEO and founder of @DISCOPharma, on breakthroughs that have improved patient outcomes, and the company’s efforts to help develop new therapies with its “surfaceome” technology. Listen to the full episode here: #episode27" target="_blank" rel="nofollow noopener">optimumcomms.com/podcast/#episo…

Meet @DISCOPharma at @HansonWade 's #WorldADC in sunny☀San Diego⛱ from 4-7 Nov to learn more about we are overcoming the challenges in ADC development using our disruptive #surfaceome mapping technology. #AntibodyDrugConjugates

Join @DISCOPharma in Dresden, 🇩🇪 for the 23rd @hupo_org World🌍Congress from 20-24 October. 💬Connect with us onsite to explore how DISCO is transforming #cancer care by expanding the molecular target🎯space with our cutting-edge #surfaceome mapping technology🦠. #HUPO2024 #EuPA

Our Head of Technology & DISCO Zürich, Emanuela Tschudy-Milani, will be attending the @festofbiologics in Basel🗻from 15-17 Oct. Reach out to connect with Emanuela onsite to learn more about our groundbreaking #surfaceome mapping technology. #FestivalofBiologics2024

Read more👉bit.ly/3zAaFwf

📰This just in! 📰 @DISCOPharma has been featured in @DDWJournal's latest article on the future of #ADCs ! We're proud to be recognised for our pioneering work in identifying novel druggable targets🎯using our disruptive #surfaceome mapping technology.

On #WorldLungDay, @DISCO Pharma is proud to support global lung health awareness. Using our breakthrough discovery platform, we've successfully mapped the #surfaceome of Small Cell #LungCancer cells and are developing target-specific therapies to improve patient care.

Learn more about DISCO here 👉 discopharma.de

There’s lots of optimism as noted in @RealEndptsMel's recent article published in @Nature's Biotechnology. Alongside other notable events, our €20m seed financing suggests the sector is headed in the right direction. Read the full article here 👉 go.nature.com/4dyZQZE

Sometimes you need to retreat from the spotlight and relax. The DISCO team sashayed its way to Karlsruhe, Germany to connect, reflect and fortify our #teambuilding skills.

On #WorldLungCancerDay, we want to raise awareness of the most aggressive form of lung cancer: #SmallCellLungCancer (#SCLC). At @DISCOPharma, we have completed the first-ever mapping of the SCLC #surfaceome. Learn more here👉discopharma.de #WLCD2024

Our CEO, Roman Thomas, spoke🎙to Janelle Hart at @Citeline , following his recognition as one of #InVivosRisingLeaders2024. Read the article to learn about our target 🎯discovery platform technology and its potential to redefine cancer #drugdiscovery: bit.ly/3Wx6lXj